T1	Participants 454 517	2367 persons in the intervention and 2162 in the control groups
T2	Participants 737 757	HIV-infected persons
T3	Participants 1113 1179	persons treated with isoniazid for developing tuberculosis of 0.58
T4	Participants 1226 1230	0.94
T5	Participants 1362 1366	0.40
